Immediate Impact

2 from Science/Nature 73 standout
Sub-graph 1 of 22

Citing Papers

Illusory generalizability of clinical prediction models
2024 StandoutScience
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
2 intermediate papers

Works of N. Keyter being referenced

Suicide Attempts in an African Schizophrenia Population: An Assessment of Demographic Risk Factors
2004
Ethnicity and Treatment Response in Schizophrenia
2002

Author Peers

Author Last Decade Papers Cites
N. Keyter 307 67 146 104 12 440
Donald H. Linszen 299 56 163 111 14 477
Yekeen A. Aderibigbe 236 75 185 68 18 508
T. Rolfe 268 80 88 62 12 462
Michael D. Teehan 303 42 115 67 22 511
Karl Leonhard 341 29 164 132 22 481
Minna Torniainen 344 54 82 59 14 461
Shubhra Mace 273 33 92 54 14 459
György Bartkó 378 50 115 175 17 437
Lilliana Dell’Osso 315 36 127 51 21 484
John Brewin 320 74 169 88 9 411

All Works

Loading papers...

Rankless by CCL
2026